WHO ICTRP trial

Clinical study of 30c and 200c potencies of individualized homeopathic medicine…

CTRI/2025/08/092457 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/08/092457
Public title Clinical study of 30c and 200c potencies of individualized homeopathic medicine in the treatment of Melasma in adult patients
Scientific title A comparative clinical study of 30c and 200c potencies of individualized homeopathic medicine in the treatment of melasma in adult patients: a randomized parallel group study - NIL
Primary sponsor Swasthya Kalyan Homeopathic Medical College And Research Centre
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Interventions Intervention1: Homeopathic medicine: Dose 4 Pills HS Potency 30C Pills number 30 route of drug administration sublingual Control Intervention1: Homeopathic Medicine: Dose 4 pills HS Potency 200C Pills number 30 Route of Drug Administration…
Registration date May 8, 2025
Target size 62
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations